Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Ra Brooimans"'
Autor:
Ra Brooimans, Lennart Nilsson, Mjjm Zvelebil, Ql Zhu, Bjm Zegers, C. I. E. Smith, Mauno Vihinen, Waterfield, Hd Ochs
Publikováno v:
Karolinska Institutet
Deficiencies in a tyrosine kinase, designated Btk, cause X-linked agammaglobulinemia (XLA) in man, a hereditary defect of B-cell differentiation. Mutations in the newly found PH domain located at the N-terminus of Btk have been shown to be the direct
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88cb951cbe16414c92a206bc30106dd6
https://pubmed.ncbi.nlm.nih.gov/7849006
https://pubmed.ncbi.nlm.nih.gov/7849006
Autor:
Manusama O; Dept of Immunology, ErasmusMC, Rotterdam, the Netherlands; Department of Internal Medicine, Division of Allergy & Clinical Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands., Singh S; Dept of Immunology, ErasmusMC, Rotterdam, the Netherlands; Department of Internal Medicine, Division of Allergy & Clinical Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands., Brooimans RA; Dept of Immunology, ErasmusMC, Rotterdam, the Netherlands; Department of Internal Medicine, Division of Allergy & Clinical Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands., Wijkhuijs A; Dept of Immunology, ErasmusMC, Rotterdam, the Netherlands; Department of Internal Medicine, Division of Allergy & Clinical Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands., van der Ent M; Dept of Immunology, ErasmusMC, Rotterdam, the Netherlands; Department of Internal Medicine, Division of Allergy & Clinical Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands., Drexhage HA; Dept of Immunology, ErasmusMC, Rotterdam, the Netherlands; Department of Internal Medicine, Division of Allergy & Clinical Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands. Electronic address: h.drexhage@erasmusmc.nl., Dalm VA; Dept of Immunology, ErasmusMC, Rotterdam, the Netherlands; Department of Internal Medicine, Division of Allergy & Clinical Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Publikováno v:
International immunopharmacology [Int Immunopharmacol] 2023 Jun; Vol. 119, pp. 110168. Date of Electronic Publication: 2023 Apr 20.
Autor:
Zhou Z; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Division of Clinical Immunology, Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Erasmus MC, Academic Center for Rare Immunological Diseases (RIDC), University Medical Center Rotterdam, Rotterdam, The Netherlands., Hollink IHIM; Erasmus MC, Academic Center for Rare Immunological Diseases (RIDC), University Medical Center Rotterdam, Rotterdam, The Netherlands.; Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Bouman A; Erasmus MC, Academic Center for Rare Immunological Diseases (RIDC), University Medical Center Rotterdam, Rotterdam, The Netherlands.; Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Lourens MS; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Erasmus MC, Academic Center for Rare Immunological Diseases (RIDC), University Medical Center Rotterdam, Rotterdam, The Netherlands., Brooimans RA; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Erasmus MC, Academic Center for Rare Immunological Diseases (RIDC), University Medical Center Rotterdam, Rotterdam, The Netherlands., van Ham TJ; Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Fraaij PLA; Erasmus MC, Academic Center for Rare Immunological Diseases (RIDC), University Medical Center Rotterdam, Rotterdam, The Netherlands.; Division of Pediatric Infectious Disease and Immunology, Department of Pediatrics, Erasmus MC, University Medical Center Rotterdam-Sophia Children's Hospital, Rotterdam, The Netherlands., van Rossum AMC; Erasmus MC, Academic Center for Rare Immunological Diseases (RIDC), University Medical Center Rotterdam, Rotterdam, The Netherlands.; Division of Pediatric Infectious Disease and Immunology, Department of Pediatrics, Erasmus MC, University Medical Center Rotterdam-Sophia Children's Hospital, Rotterdam, The Netherlands., Zijtregtop EAM; Division of Pediatric Hemato-oncology, Department of Pediatrics, Erasmus MC, University Medical Center Rotterdam-Sophia Children's Hospital, Rotterdam, The Netherlands., Dik WA; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Erasmus MC, Academic Center for Rare Immunological Diseases (RIDC), University Medical Center Rotterdam, Rotterdam, The Netherlands., Dalm VASH; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Division of Clinical Immunology, Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Erasmus MC, Academic Center for Rare Immunological Diseases (RIDC), University Medical Center Rotterdam, Rotterdam, The Netherlands., van Hagen PM; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Division of Clinical Immunology, Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Erasmus MC, Academic Center for Rare Immunological Diseases (RIDC), University Medical Center Rotterdam, Rotterdam, The Netherlands., Ijspeert H; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Erasmus MC, Academic Center for Rare Immunological Diseases (RIDC), University Medical Center Rotterdam, Rotterdam, The Netherlands., Vermont CL; Erasmus MC, Academic Center for Rare Immunological Diseases (RIDC), University Medical Center Rotterdam, Rotterdam, The Netherlands.; Division of Pediatric Infectious Disease and Immunology, Department of Pediatrics, Erasmus MC, University Medical Center Rotterdam-Sophia Children's Hospital, Rotterdam, The Netherlands.
Publikováno v:
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology [Pediatr Allergy Immunol] 2022 Apr; Vol. 33 (4), pp. e13768.
Autor:
Schrijver B; Department of Immunology, Laboratory Medical Immunology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands.; Rare Immune Diseases Center, Erasmus MC Medical Center, Rotterdam, the Netherlands., Hardjosantoso H; Rare Immune Diseases Center, Erasmus MC Medical Center, Rotterdam, the Netherlands.; Department of Ophthalmology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands., Ten Berge JCEM; Rare Immune Diseases Center, Erasmus MC Medical Center, Rotterdam, the Netherlands.; Department of Ophthalmology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands., Schreurs MWJ; Department of Immunology, Laboratory Medical Immunology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands.; Rare Immune Diseases Center, Erasmus MC Medical Center, Rotterdam, the Netherlands., Van Hagen PM; Department of Immunology, Laboratory Medical Immunology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands.; Rare Immune Diseases Center, Erasmus MC Medical Center, Rotterdam, the Netherlands.; Department of Internal Medicine, Section Clinical Immunology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands., Brooimans RA; Department of Immunology, Laboratory Medical Immunology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands.; Rare Immune Diseases Center, Erasmus MC Medical Center, Rotterdam, the Netherlands., Rothova A; Rare Immune Diseases Center, Erasmus MC Medical Center, Rotterdam, the Netherlands.; Department of Ophthalmology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands., Dik WA; Department of Immunology, Laboratory Medical Immunology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands.; Rare Immune Diseases Center, Erasmus MC Medical Center, Rotterdam, the Netherlands.
Publikováno v:
Ocular immunology and inflammation [Ocul Immunol Inflamm] 2021 Jul 04; Vol. 29 (5), pp. 883-889. Date of Electronic Publication: 2020 Jan 08.
Autor:
Brooimans RA; Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands; Laboratory of Clinical and Tumor Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands. Electronic address: r.brooimans@erasmusmc.nl., van der Velden VHJ; Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Boeckx N; Laboratory of Experimental Transplantation, University of Leuven, Leuven, Belgium., Slomp J; Department of Clinical Chemistry, Medisch Spectrum Twente/Medlon, Enschede, The Netherlands., Preijers F; Department of Laboratory Medicine-Laboratory for Hematology, Radboud UMC, Nijmegen, The Netherlands., Te Marvelde JG; Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Van NM; Laboratory of Clinical and Tumor Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Heijs A; Department of Clinical Chemistry, Medisch Spectrum Twente/Medlon, Enschede, The Netherlands., Huys E; Department of Laboratory Medicine-Laboratory for Hematology, Radboud UMC, Nijmegen, The Netherlands., van der Holt B; Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., de Greef GE; Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Kelder A; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands., Schuurhuis GJ; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands.
Publikováno v:
Leukemia research [Leuk Res] 2019 Jan; Vol. 76, pp. 39-47. Date of Electronic Publication: 2018 Nov 27.
Autor:
Preijers FW; Laboratory of Hematology, Department of Laboratory Medicine, Radboud UMC, Nijmegen, The Netherlands., van der Velden VH; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Preijers T; Laboratory of Hematology, Department of Laboratory Medicine, Radboud UMC, Nijmegen, The Netherlands., Brooimans RA; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Marijt E; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Homburg C; Department of Immunocytology, Sanquin Blood Supply, Amsterdam, The Netherlands., van Montfort K; Department of Trials and Statistics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Gratama JW; Department of Internal Oncology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
Publikováno v:
Cytometry. Part B, Clinical cytometry [Cytometry B Clin Cytom] 2016 May; Vol. 90 (3), pp. 267-78. Date of Electronic Publication: 2015 Jul 31.
Autor:
de Jongste AH; Department of Medical Oncology, Erasmus University Medical Center/Daniel Den Hoed Cancer Center, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands; Department of Neurology, Erasmus University Medical Center, Rotterdam's-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands., Kraan J, van den Broek PD, Brooimans RA, Bromberg JE, van Montfort KA, Smitt PA, Gratama JW
Publikováno v:
Cytometry. Part B, Clinical cytometry [Cytometry B Clin Cytom] 2014 Jul; Vol. 86 (4), pp. 272-9. Date of Electronic Publication: 2013 May 14.
Autor:
Wilson WH; Lymphoid Malignancy Branch, National Cancer Institute, Bethesda, MD, USA wilsonw@mail.nih.gov., Bromberg JE; Department of Neuro-Oncology, Daniel den Hoed Cancer Center, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Stetler-Stevenson M; Lymphoid Malignancy Branch, National Cancer Institute, Bethesda, MD, USA., Steinberg SM; Lymphoid Malignancy Branch, National Cancer Institute, Bethesda, MD, USA., Martin-Martin L; Department of Medicine and Centro de Investigacion del Cancer (IBMCC-CSIC/USAL) and Department of Hematology, University Hospital, IBSAL and University of Salamanca, Salamanca, Spain., Muñiz C; Department of Medicine and Centro de Investigacion del Cancer (IBMCC-CSIC/USAL) and Department of Hematology, University Hospital, IBSAL and University of Salamanca, Salamanca, Spain., Sancho JM; Department of Hematology, Hospital German Trias i Puyol, University of Barcelona, Spain for the Spanish Group for the Study of CNS Disease in NHL., Caballero MD; Department of Medicine and Centro de Investigacion del Cancer (IBMCC-CSIC/USAL) and Department of Hematology, University Hospital, IBSAL and University of Salamanca, Salamanca, Spain., Davidis MA; Department of Hematology, Daniel den Hoed Cancer Center, Erasmus MC, University Medical Center Rotterdam, The Netherlands., Brooimans RA; Department of Medical Immunology, Daniel den Hoed Cancer Center, Erasmus MC, University Medical Center Rotterdam, The Netherlands., Sanchez-Gonzalez B; Department of Hematology, Hospital del Mar, Barcelona, Spain., Salar A; Department of Hematology, Hospital del Mar, Barcelona, Spain., González-Barca E; Department of Hematology, Hospital Duran i Reynals, Institut Catala d'Oncologia, IDIBELL, University of Barcelona, Spain., Ribera JM; Department of Hematology, Hospital German Trias i Puyol, University of Barcelona, Spain for the Spanish Group for the Study of CNS Disease in NHL., Shovlin M; Lymphoid Malignancy Branch, National Cancer Institute, Bethesda, MD, USA., Filie A; Lymphoid Malignancy Branch, National Cancer Institute, Bethesda, MD, USA., Dunleavy K; Lymphoid Malignancy Branch, National Cancer Institute, Bethesda, MD, USA., Mehrling T; Mundipharma International Limited, Cambridge, UK., Spina M; Division of Medical Oncology A, National Cancer Institute, Aviano, Italy., Orfao A; Department of Medicine and Centro de Investigacion del Cancer (IBMCC-CSIC/USAL) and Department of Hematology, University Hospital, IBSAL and University of Salamanca, Salamanca, Spain.
Publikováno v:
Haematologica [Haematologica] 2014 Jul; Vol. 99 (7), pp. 1228-35. Date of Electronic Publication: 2014 Apr 11.
Autor:
Terwijn M; Monique Terwijn, Angèle Kelder, Peter C. Huijgens, Angelika M. Dräger, Yvonne J.M. Oussoren, Willemijn J. Scholten, Alexander N. Snel, Gert J. Ossenkoppele, and Gerrit J. Schuurhuis, VU University Medical Centre; Bart J. Biemond, Academic Medical Centre, Amsterdam; Wim L.J. van Putten, Vincent H.J. van der Velden, Georgine E. de Greef, Peter J.M. Valk, Mojca Jongen-Lavrecic, and Bob Löwenberg, Erasmus University Medical Centre; Rik A. Brooimans, Jan W. Gratama, Erasmus University Medical Centre/Daniel den Hoed Cancer Centre, Rotterdam; Frank W.M.B. Preijers, Radboud University Nijmegen Medical Center, Nijmegen; Michel van Gelder, University Medical Centre, Maastricht; Pierre Wijermans, Haga Hospital, The Hague; Marie-Cecile Legdeur and Jennita Slomp, Medisch Spectrum Twente, Enschede; Jurgen Kuball, University Medical Center Utrecht; Okke de Weerdt, St. Antonius Hospital, Nieuwegein; Leo F. Verdonck, Isala Clinics, Zwolle, the Netherlands; Thomas Pabst, Bern University Hospital, Bern; Urs Schanz, University Hospital, Zürich; Jakob R. Passweg, Basel University Hospital, Basel; Mario Bargetzi, Kantonspital, Aarau; Yves Chalandon, University Hospital of Geneva, Geneva; Urs Hess, Kantonsspital, St. Gallen, Switzerland; Johan Maertens, University Hospital Gasthuisberg; Nancy Boeckx, University Hospitals Leuven and Katholieke Universiteit Leuven, Leuven; Carlos Graux, Cliniques Universitaires-Université Catholique de Louvain, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, St. Luc Hospital, Brussels, Belgium., van Putten WL, Kelder A, van der Velden VH, Brooimans RA, Pabst T, Maertens J, Boeckx N, de Greef GE, Valk PJ, Preijers FW, Huijgens PC, Dräger AM, Schanz U, Jongen-Lavrecic M, Biemond BJ, Passweg JR, van Gelder M, Wijermans P, Graux C, Bargetzi M, Legdeur MC, Kuball J, de Weerdt O, Chalandon Y, Hess U, Verdonck LF, Gratama JW, Oussoren YJ, Scholten WJ, Slomp J, Snel AN, Vekemans MC, Löwenberg B, Ossenkoppele GJ, Schuurhuis GJ
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2013 Nov 01; Vol. 31 (31), pp. 3889-97. Date of Electronic Publication: 2013 Sep 23.
Autor:
Feller N; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands., van der Velden VH, Brooimans RA, Boeckx N, Preijers F, Kelder A, de Greef I, Westra G, Te Marvelde JG, Aerts P, Wind H, Leenders M, Gratama JW, Schuurhuis GJ
Publikováno v:
Blood cancer journal [Blood Cancer J] 2013 Aug 02; Vol. 3, pp. e129. Date of Electronic Publication: 2013 Aug 02.